U-Chart Analysis:PeptiDream Inc.:4587

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index PeptiDream Inc. Go to web site 4587 Medicals 東証プライム December 1, 2000 2013.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

PeptiDream Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

PeptiDream Inc. Balance Sheet 2024年12月期 PeptiDream Inc. Balance Sheet 2023年12月期 PeptiDream Inc. Balance Sheet 2022年12月期 PeptiDream Inc. Balance Sheet 2021年12月期 PeptiDream Inc. Balance Sheet 2020年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents 48,118 19,508 5,248 11,747 7,149
Other Current AssetsHelp 9,092 7,717 19,825 2,090 8,492
Tangible Fixed AssetsHelp 17,526 17,358 18,125 6,437 5,767
Intangible Fixed AssetHelp 2,143 2,211 2,233 76 79
Investments and OthersHelp 7,520 14,298 10,064 -1,685 -3,591
Total AssetsHelp 92,770 69,464 63,865 27,035 26,267
Total Current LiabilitiesHelp 18,966 9,480 13,466 1,684 5,050
Total Long-term LiabilitiesHelp 17,042 19,634 18,358 0 0
Shareholder's EquityHelp 56,762 40,350 32,041 25,350 21,217
Total LiabilitiesHelp 92,770 69,464 63,865 27,035 26,267

PeptiDream Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

PeptiDream Inc. Profit and Loss Account 2024年12月期 PeptiDream Inc. Profit and Loss Account 2023年12月期 PeptiDream Inc. Profit and Loss Account 2022年12月期 PeptiDream Inc. Profit and Loss Account 2021年12月期 PeptiDream Inc. Profit and Loss Account 2020年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales 46,677 28,712 26,852 9,422 11,677
Total Sales 46,677 28,712 26,852 9,422 11,677
Cost of SalesHelp 12,173 11,493 8,739 2,393 2,148
Other Costs and RevenueHelp 19,489 14,183 10,559 4,456 5,081
Total CostsHelp 31,662 25,676 19,298 6,849 7,229
Net RevenueHelp 34,504 17,219 18,113 7,029 9,529
Earnings Before TaxHelp 20,889 4,353 6,653 3,804 6,020
Net IncomeHelp 15,015 3,036 7,554 2,573 4,448
Net Income 15,015 3,036 7,554 2,573 4,448

PeptiDream Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

PeptiDream Inc. Cash Flow Statement 2024年12月期 PeptiDream Inc. Cash Flow Statement 2023年12月期 PeptiDream Inc. Cash Flow Statement 2022年12月期 PeptiDream Inc. Cash Flow Statement 2021年12月期 PeptiDream Inc. Cash Flow Statement 2020年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help 23,845 12,421 -83 6,655 1,733
Investing Cash Flow(ICF)Help 8,371 1,303 -27,377 -2,283 -1,200
Financing Cash FlowHelp -2,995 264 20,789 66 -237
Exchange Difference of Cash and Cash EquivalentsHelp -611 272 172 160 -133
Net Increase and Decrease in Cash and Cash Equivalentsn 28,610 14,260 -6,499 4,597 163

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

PeptiDream Inc.
Roland DG Corporation
NISSAN MOTOR CO.,LTD.
ADVAX Corporation
LIFENET INSURANCE COMPANY

Company where related level is highHelp

MUROMACHI CHEMICALS INC.
RaQualia Pharma Inc.
TOWA PHARMACEUTICAL CO.,LTD.
TORII PHARMACEUTICAL CO.,LTD.
SSP CO.,LTD.
Toyama Chemical Co.,Ltd.
Noile-Immune Biotech Inc.
RIBOMIC Inc.
TAISHO PHARMACEUTICAL CO.,LTD.
HISAMITSU PHARMACEUTICAL CO.,INC.